Clinical trials recruiting in Blackburn, United Kingdom
6
Recruiting trials
13
Conditions
Phase breakdown
Phase 3 5Not applicable 1
Conditions recruiting in Blackburn, United Kingdom
Recruiting trials in Blackburn, United Kingdom
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
Common questions
How many clinical trials are recruiting in Blackburn, United Kingdom?
6 recruiting trials have at least one study site in Blackburn, United Kingdom.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.